Qcm Cayman, Ltd. Novavax Inc Transaction History

Qcm Cayman, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $293,748 - $831,818	-2,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $19,621 - $44,091	-247 Reduced 8.68%	2,600 $282,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $39,459 - $238,037	2,847 New	2,847 $237,000

284

83.2M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $988M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.